Skip to content
Unrated Drug recall · FDA · Published February 21, 2022

Morton Grove Dexamethasone Elixir Recall: Impurities Risk Health

Morton Grove Pharmaceuticals recalls Dexamethasone Elixir due to higher than permissible impurities. This prescription drug may pose health risks if used. Check your bottle's lot number for affected batches.

🇺🇸 FDA recall #D-0713-2022DrugMorton Grove ›
Take action

Contact the company

Recalling firmMorton Grove Pharmaceuticals, Inc.6451 Main St · Morton Grove, IL 60053-2633
✎ GovInfoNow plain-language explainer

Morton Grove Pharmaceuticals is recalling Dexamethasone Elixir because it contains impurities at levels above what's safe. This could lead to health issues if taken as directed. Read more at govinfonow.com/recall/35210-morton-grove-dexamethasone-elixir-recall-impurities-risk-health.

Source Summary by GovInfoNow · govinfonow.com/recall/35210-morton-grove-dexamethasone-elixir-recall-impurities-risk-health · Updated August 18, 2026 · FDA enforcement record: FDA #D-0713-2022

Cite this page

“Morton Grove Dexamethasone Elixir Recall: Impurities Risk Health.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/35210-morton-grove-dexamethasone-elixir-recall-impurities-risk-health. Based on FDA recall #D-0713-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0713-2022%22&limit=1).

The FDA announced on Feb. 21, 2022, that Morton Grove Pharmaceuticals voluntarily recalled Dexamethasone Elixir due to failed impurity specifications. The agency stated the recall was initiated by the firm.

How to tell if you have it

  • Brand: Morton Grove
  • Product: Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only
  • NDC: 60432-466-08
  • Lot codes: UV1004, UV1005, UW1014, UW1015, UW1084
  • Expiration dates: 6/22, 1/23, 7/23

The hazard

The recall was issued because higher than permissible levels of unknown impurities were found in the drug product. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Morton Grove Pharmaceuticals, Inc. has had six other recalls since Dec. 15, 2015. Other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection Recall (Feb. 4, 2026), Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026), and Zydus Mirabegron 25mg Tablets Recall (Aug. 5, 2026).

How to tell if you have this one

Check the bottle for the label 'Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL)'. Look for lot numbers UV1004, UV1005 (expiring 6/22), UW1014, UW1015 (expiring 1/23), or UW1084 (expiring 7/23).

  • Brand
    Morton Grove
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Look for the specific lot numbers listed in the recall: UV1004, UV1005 (expiring 6/22), UW1014, UW1015 (expiring 1/23), or UW1084 (expiring 7/23).

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.5 years after the firm started it.

1. Firm started the recall: Feb 21, 202212. Published in FDA’s Enforcement Report: Mar 9, 202223. FDA classified it Class II: Mar 21, 202234. FDA terminated the recall: Aug 6, 2024420222024
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0713-2022 (February 21, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0713-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA